Mehmet Asim Bilen MD

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 73

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Article

CD8+T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

by Nataliya Prokhnevska; Maria A Cardenas; Rajesh M Valanparambil; Ewelina Sobierajska; Benjamin Barwick; Caroline Jansen; Adriana Reyes Moon; Petra Gregorova; Luke delBalzo; Rachel Greenwald; Mehmet Bilen; Mehrdad Alemozaffar; Shreyas Joshi; Cara Cimmino; Christian Larsen; Viraj Master; Martin Sanda; Haydn Kissick

2023

Article

Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

by Dimitrios Makrakis; Rafee Talukder; Leonidas N Diamantopoulos; Lucia Carril-Ajuria; Daniel Castellano; Ivan De Kouchkovsky; Vadim S Koshkin; Joseph J Park; Ajjai Alva; Mehmet Bilen; Tyler F Stewart; Rana R McKay; Victor S Santos; Neeraj Agarwal; Jayanshu Jain; Yousef Zakharia; Rafael Morales-Barrera; Michael E Devitt; Michael Grant; Mark P Lythgoe; David J Pinato; Ariel Nelson; Christopher J Hoimes; Evan Shreck; Benjamin A Gartrell; Alex Sankin; Abhishek Tripathi; Roubini Zakopoulou; Aristotelis Bamias; Jure Murgic; Ana Fröbe; Alejo Rodriguez-Vida; Alexandra Drakaki; Sandy Liu; Vivek Kumar; Giuseppe Di Lorenzo; Monika Joshi; Pedro Isaacsson-Velho; Lucia Alonso Buznego; Ignacio Duran; Marcus Moses; Pedro Barata; Guru Sonpavde; Evan Y Yu; Jonathan L Wright; Petros Grivas; Ali Raza Khaki

2021

Article

Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

by Dimitrios Makrakis; Rafee Talukder; Genevieve I Lin; Leonidas N Diamantopoulos; Scott Dawsey; Shilpa Gupta; Lucia Carril-Ajuria; Daniel Castellano; Ivan de Kouchkovsky; Vadim S Koshkin; Joseph J Park; Ajjai Alva; Mehmet Bilen; Tyler F Stewart; Rana R McKay; Nishita Tripathi; Neeraj Agarwal; Naomi Vather-Wu; Yousef Zakharia; Rafael Morales-Barrera; Michael E Devitt; Alessio Cortellini; Claudia Angela Maria Fulgenzi; David J Pinato; Ariel Nelson; Christopher J Hoimes; Kavita Gupta; Benjamin A Gartrell; Alex Sankin; Abhishek Tripathi; Roubini Zakopoulou; Aristotelis Bamias; Jure Murgic; Ana Fröbe; Alejo Rodriguez-Vida; Alexandra Drakaki; Sandy Liu; Eric Lu; Vivek Kumar; Guiseppe D Lorenzo; Monika Joshi; Pedro Isaacsson-Velho; Lucia A Buznego; Ignacio Duran; Marcus Moses; Albert Jang; Pedro Barata; Guru Sonpavde; Evan Y Yu; Robert Bruce Montgomery; Petros Grivas; Ali Raza Khaki

2022

Article

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

by Melissa YY Moey; Cassandra Hennessy; Benjamin French; Jeremy L Warner; Matthew D Tucker; Daniel J Hausrath; Dimpy P Shah; Jeanne M DeCara; Ziad Bakouny; Chris Labaki; Toni K Choueiri; Susan Dent; Nausheen Akhter; Roohi Ismail-Khan; Lisa Tachiki; David Slosky; Tamar S Polonsky; Joy A Awosika; Audrey Crago; Trisha Wise-Draper; Nino Balanchivadze; Clara Hwang; Leslie A Fecher; Cyndi Gonzalez Gomez; Brandon Hayes-Lattin; Michael J Glover; Sumit A Shah; Dharmesh Gopalakrishnan; Elizabeth A Griffiths; Daniel H Kwon; Vadim S Koshkin; Sana Mahmood; Babar Bashir; Taylor Nonato; Pedram Razavi; Rana R McKay; Gayathri Nagaraj; Eric Oligino; Matthew Puc; Polina Tregubenko; Elizabeth M Wulff-Burchfield; Zhuoer Xie; Thorvardur R Halfdanarson; Dimitrios Farmakiotis; Elizabeth J Klein; Elizabeth V Robilotti; Gregory J Riely; Jean-Bernard Durand; Salim S Hayek; Lavanya Kondapalli; Stephanie Berg; Timothy E O'Connor; Mehmet Bilen; Cecillia Castellano; Melissa K Accordino; Blau Sibel; Lisa B Weissmann; Chinmay Jani; Daniel B Flora; Lawrence Rudski; Miriam Santos Dutra; Bouganim Nathaniel; Erika Ruiz-Garcia; Diana Vilar-Compte; Shilpa Gupta; Alicia Morgans; Anju Nohria

2023

Article

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer

by Agreen Hadadi; Katherine ER Smith; Limeng Wan; Jacqueline R Brown; Greta Russler; Lauren Yantorni; Sarah Caulfield; Jennifer Lafollette; Melvin Moore; Omer Kucuk; Bradley Carthon; Bassel Nazha; Yuan Liu; Mehmet Bilen

2022

Article

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

by Rafee Talukder; Dimitrios Makrakis; Genevieve I Lin; Leonidas N Diamantopoulos; Scott Dawsey; Shilpa Gupta; Lucia Carril-Ajuria; Daniel Castellano; Ivan de Kouchkovsky; Tanya Jindal; Vadim S Koshkin; Joseph J Park; Ajjai Alva; Mehmet Bilen; Tyler F Stewart; Rana R McKay; Nishita Tripathi; Neeraj Agarwal; Naomi Vather-Wu; Yousef Zakharia; Rafael Morales-Barrera; Michael E Devitt; Alessio Cortellini; Claudia AM Fulgenzi; David J Pinato; Ariel Nelson; Christopher J Hoimes; Kavita Gupta; Benjamin A Gartrell; Alex Sankin; Abhishek Tripathi; Roubini Zakopoulou; Aristotelis Bamias; Jure Murgic; Ana Fröbe; Alejo Rodriguez-Vida; Alexandra Drakaki; Sandy Liu; Eric Lu; Vivek Kumar; Giuseppe Di Lorenzo; Monika Joshi; Pedro Isaacsson-Velho; Lucia Alonso Buznego; Ignacio Duran; Marcus Moses; Pedro Barata; Guru Sonpavde; Jonathan L Wright; Evan Y Yu; Robert Bruce Montgomery; Andrew C Hsieh; Petros Grivas; Ali Raza Khaki

2022

Article

Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin

by Rafee Talukder; Dimitrios Makrakis; Leonidas N Diamantopoulos; Lucia Carril-Ajuria; Daniel Castellano; Ivan De Kouchkovsky; Vadim S Koshkin; Joseph J Park; Ajjai Alva; Mehmet Bilen; Tyler F Stewart; Rana R McKay; Victor S Santos; Neeraj Agarwal; Jayanshu Jain; Yousef Zakharia; Rafael Morales-Barrera; Michael E Devitt; Michael Grant; Mark P Lythgoe; David J Pinato; Ariel Nelson; Christopher J Hoimes; Evan Shreck; Benjamin A Gartrell; Alex Sankin; Abhishek Tripathi; Roubini Zakopoulou; Aristotelis Bamias; Jure Murgic; Ana Fröbe; Alejo Rodriguez-Vida; Alexandra Drakaki; Sandy Liu; Vivek Kumar; Giuseppe Di Lorenzo; Monika Joshi; Pedro Isaacsson Velho; Lucia Alonso Buznego; Ignacio Duran; Marcus Moses; Pedro Barata; Guru Sonpavde; Evan Y Yu; Jonathan L Wright; Petros Grivas; Ali Raza Khaki

2022

Article

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naive patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)

by Michael B Atkins; Opeyemi A Jegede; Naomi B Haas; David F McDermott; Mehmet Bilen; Mark Stein; Jeffrey A Sosman; Robert Alter; Elizabeth R Plimack; Moshe C Ornstein; Michael Hurwitz; David J Peace; Sabina Signoretti; Thomas Denize; Alessia Cimadamore; Catherine J Wu; David Braun; David Einstein; Paul J Catalano; Hans Hammers

2023

Article

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma

by Deepak Ravindranathan; Douglas B Johnson; Michael B Atkins; Cassandra Hennessy; Trisha Wise-Draper; Hannah Heilman; Joy Awosika; Ziad Bakouny; Chris Labaki; Renee Maria Saliby; Clara Hwang; Sunny RK Singh; Nino Balanchivadze; Christopher R Friese; Leslie A Fecher; James J Yoon; Brandon Hayes-Lattin; Mehmet Bilen; Cecilia A Castellano; Gary H Lyman; Lisa Tachiki; Sumit A Shah; Michael J Glover; Daniel B Flora; Elizabeth Wulff-Burchfield; Anup Kasi; Saqib H Abbasi; Dimitrios Farmakiotis; Kendra Viera; Elizabeth J Klein; Lisa B Weissman; Chinmay Jani; Matthew Puc; Catherine C Fahey; Daniel Y Reuben; Sanjay Mishra; Alicia Beeghly-Fadiel; Benjamin French; Jeremy L Warner

2023

Article

Editorial: Case reports in renal cell carcinoma

by Tony Z Zhuang; Seema M Mustafa; Kathryn E Beckermann; Mehmet Bilen

2023